C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Clinical trial NCT03635632 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03635632
Sponsor: Baylor College of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Neuroblastoma Refractory Neuroblastoma Relapsed Osteosarcoma Relapsed Ewing Sarcoma Relapsed Rhabdomyosarcoma Uveal Melanoma Phyllodes Breast Tumor

Start date: 2019-04-23
Primary completion: 2023-05-16
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.